BURU compared with LIMN: revenue, margins and what each company keeps, and the suppliers and customers both name

BURUNuburu, Inc.

Mkt capRevenueRevenue

LIMNLiminatus Pharma, Inc.

Mkt capRevenueRevenue

Compare

BURUNuburu, Inc.

LIMNLiminatus Pharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

BURU: latest quarter is a loss; flow not drawable. LIMN: latest quarter not drawable.Method ›

BURUNuburu, Inc.

0.25· pre 0.24· delayed

Mkt cap$1.3MRevenue$524,927Q2 FY26

LIMNLiminatus Pharma, Inc.

2.92· pre 2.86· delayed

Pre-marketNov 3 '26delayed

Mkt cap$2.4MRevenue—

Compare

Pre-marketNov 3 '26delayed

BURUNuburu, Inc.

LIMNLiminatus Pharma, Inc.

0.25pre 0.24delayed

Price

2.92pre 2.86delayed

$1.3M

Mkt cap

$2.4M

Q2 FY26$524,927

Revenue

—

BURU0.25vsLIMN2.92Pre-marketNov 3 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only BURU 5

—Undisclosed customerunlistedcustomer

—Orbit S.r.lunlistedsupplier

—Tceiunlistedsupplier

—Tekneunlistedsupplier

1 more · BURU chain ›

Shared 0

No disclosed counterparties: LIMN.

Only LIMN 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

BURU, solidLIMN, dashed